abstract |
Described are methods of treating cardiovascular diseases in smokers and/or subjects ingesting or consuming nicotine from other sources (e-cigarettes/vaping, smokeless tobacco, NRT, etc.) by using anti-nicotine agents such as nicotine-binding antibodies or nicotine- degrading enzymes, as well as anti-nicotine agents for use in such methods. |